Table 3: Comparison of demographic, physical and clinical characteristics and treatment modalities of patients with TOA (n = 193).

Parameter

Medical Threatment (n = 68)

Surgical Threatment (n = 125)

P value

Age (year)

39.1 ± 8.4 (22-64)

40.9 ± 6.6 (23-56)

0.084

BMI (kg/m2)

27.3 ± 4.6 (20-41)

28.4 ± 5.0 (16-44)

0.263

Smoking

39 (%57.3)

65 (%52)

0.172

IUD

29 (%42.6)

63 (%52.9)

0.007

Past history of PID

4 (%5.8)

9 (%7.2)

0.469

Cesarean delivery

16 (%23.5)

32 (%25.6)

0.347

Prior pelvic surgery

24 (%35.2)

43 (%34.4)

0.352

Prior intrauterine surgery

26 (%38.2)

50 (%40)

0.329

Length of stay in hospital (days)

11.3 ± 4.2 (2-20)

15.2 ± 4.9 (3-30)

0.318

White cell (/mm3)

11,884 ± 4,684

14,254 ± 5,182

0.004

CRP (mg/L)

85.9 ± 78.8

152.3 ± 105.5

0.000

Abscess location

·         Unilateral

·         Bilateral

n (%)

50 (%73.5)

18 (%26.5)

n (%)

91 (%72.8)

34 (%27.2)

 

0.002

Largest abscess size (mm)

60.7 ± 21.4 (33-123)

70.5 ± 18.7 (30-133)

0.021

Recurrence

8 (%11.7)

4 (%3.2)

0.031

CRP: C-Reactive Protein; PID: Pelvic Inflammatory Disease; IUD: Intrauterine Device; BMI: Body Mass Index